文献速递骨肌胸部技术与安全CT

自体造血干细胞移植后胸椎CT骨小梁衰减变化

Vertebral trabecular attenuation serial changes on chest CT after autologous hematopoietic stem cell transplantation.
PubMed 文献 · Skeletal Radiol · 2026-07-27

该回顾性单中心研究纳入98例接受自体造血干细胞移植且具有移植前及移植后30天内平扫胸部CT的成人患者,测量T10-T12椎体骨小梁衰减和椎体高度,61例具有30天后晚期随访CT。结果显示椎体骨小梁衰减在移植后早期显著降低并持续维持低值,椎体高度在晚期随访时显著下降。

要点

  • 常规胸部CT可机会性测量T10-T12椎体骨小梁衰减,无需额外扫描。
  • 移植后30天内椎体骨小梁衰减即显著下降,提示骨骼脆弱性出现较早。
  • 衰减值≤110 HU可提示骨质疏松范围,移植后该比例明显升高。

核心结论

  • 自体造血干细胞移植后一个月内椎体骨小梁衰减即显著下降,并在随访影像上持续维持低值。
  • 基于常规胸部CT的机会性评估可能有助于早期识别骨骼脆弱性。

研究设计与样本

  • 回顾性单中心研究,纳入98例接受自体造血干细胞移植且具有移植前和移植后早期(≤30天)平扫胸部CT的成人患者。
  • 在61例具有晚期随访CT(>30天)的患者中额外评估纵向变化。
  • 以HU为单位测量T10-T12椎体骨小梁衰减,以毫米为单位测量椎体高度。

关键影像表现/征象

  • 椎体骨小梁衰减在常规胸部CT上表现为T10-T12椎体松质骨区域HU值降低。
  • 骨小梁衰减值≤110 HU提示处于骨质疏松范围。

诊断标准与关键数值

  • 椎体骨小梁衰减从移植前163.0 ± 57.0 HU显著下降至移植后早期132.7 ± 53.9 HU(p < 0.001)。
  • 在具有晚期随访影像的患者中,椎体骨小梁衰减从基线157.3 ± 58.7 HU降至125.3 ± 56.1 HU(p < 0.001)。
  • 骨质疏松范围(≤110 HU)的比例从基线20.4%升高至移植后早期39.8%。
  • 在具有晚期随访影像的患者中,骨质疏松范围比例从27.4%升高至移植后早期45.2%,晚期随访时仍为48.4%。

临床应用与阅片要点

  • 报告常规胸部CT时可附带记录T10-T12椎体骨小梁衰减,作为骨骼健康的辅助信息。
  • 自体造血干细胞移植患者胸部CT出现骨小梁衰减下降时,应提示临床关注骨骼脆弱性和骨折风险。
  • 椎体高度在移植后早期无明显变化,晚期随访时显著下降,需注意识别新发椎体压缩性改变。

局限性

  • 该研究为单中心回顾性设计。
  • 仅61例患者具有晚期随访CT,晚期样本量少于总体样本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Transplant-associated bone disease and fragility fractures are recognized complications after hematopoietic stem cell transplantation (HSCT). We aimed to evaluate early and longitudinal changes in vertebral trabecular attenuation on routine chest CT in patients undergoing autologous HSCT.

MATERIALS AND METHODS: In this retrospective single-centre study, 98 adult patients who underwent autologous HSCT and had both pre-transplant and early post-transplant (≤ 30 days) non-contrast chest CT were included. Vertebral trabecular attenuation was measured in Hounsfield units (HU) at T10-T12 and vertebral body height was measured in millimeters. Longitudinal changes were additionally evaluated in patients with available late follow-up CT (> 30 days) (n = 61).

RESULTS: Vertebral trabecular attenuation decreased significantly from pre-transplant to early post-transplant CT (163.0 ± 57.0 HU vs. 132.7 ± 53.9 HU; p < 0.001). In patients with late follow-up imaging, attenuation remained lower than baseline (157.3 ± 58.7 HU vs. 125.3 ± 56.1 HU; p < 0.001). The proportion of attenuation values within the osteoporosis range (≤ 110 HU) increased from 20.4% at baseline to 39.8% early after transplantation. Among patients with late follow-up imaging, this proportion increased from 27.4% to 45.2% early after transplantation and remained elevated at 48.4% at late follow-up. Vertebral body height remained unchanged during the early post-transplant period but decreased significantly at late follow-up.

CONCLUSION: Vertebral trabecular attenuation on routine chest CT declines within the first month after autologous HSCT and remains reduced on follow-up imaging. Opportunistic CT-based assessment may enable early identification of skeletal vulnerability.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Atçeken, Kula, Tan, et al. Vertebral trabecular attenuation serial changes on chest CT after autologous hematopoietic stem cell transplantation. Skeletal Radiol. 2026. PMID: 42509339. doi:10.1007/s00256-026-05316-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。